EMFAT
INSY

Emerald Mutual Fund Advisers Trust’s Insys Therapeutics, Inc. INSY Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-229,023
Closed -$2.96M – 241
2013
Q4 		$2.96M Sell
229,023
-402,600
-64% -$5.58M 0.37% 91
2013
Q3 		$7.37M Sell
631,623
-23,520
-4% -$193K 1.02% 29
2013
Q2 		$3.02M Buy
+655,143
New +$2.4M 0.51% 80

Other funds holding INSY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's INSY Position: Q1 2014 in Review

Emerald Mutual Fund Advisers Trust sold out of Insys Therapeutics, Inc. (INSY) in Q1 2014, closing a stake of 229,023 shares — an estimated $2.96M sold.

Emerald Mutual Fund Advisers Trust first reported a position in INSY in Q2 2013 and held it in 3 quarters. The position peaked at $7.37M in Q3 2013. 99 funds tracked by Wall St. Rank hold INSY as of Q1 2014.

  • Emerald Mutual Fund Advisers Trust reported no remaining Insys Therapeutics, Inc. position as of Q1 2014 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 229,023 Insys Therapeutics, Inc. shares in Q1 2014, an estimated $2.96M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 3 quarters.
  • Emerald Mutual Fund Advisers Trust's Insys Therapeutics, Inc. position peaked at $7.37M in Q3 2013.
  • 99 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2014.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2014, filed 30 Apr 2014.